Black cohosh (Cimicifuga racemosa): a systematic review of adverse events

      Black cohosh (Cimicifuga racemosa) is used most often to treat symptoms that can occur during menopause. However, in the last years, several concerns regarding its safety have been voiced. The aim of this systematic review was to evaluate the clinical evidence for or against the safety of black cohosh. Systematic literature searches were conducted in 5 computerized databases (Medline, Embase, Amed, Phytobase, and Cochrane Library). The references of all located articles were scanned for further relevant publications. Any type of clinical data that included case reports and observational studies was considered. No language restrictions were imposed. Thirteen clinical trials (all of which indicated relative safety), 3 postmarketing surveillance studies, 4 case series, and 8 single case reports were identified. Clinical studies suggest black cohosh to be safe. In most case reports, causal attribution is problematic. In conclusion, black cohosh has been associated with serious safety concerns that urgently require further investigation.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Eisenberg D.
        • David R.B.
        • Ettner S.L.
        • et al.
        Trends in alternative medicine use in the United States; 1990-1997.
        JAMA. 1998; 280: 1569-1575
        • Tindle H.A.
        • Davis R.B.
        • Phillips R.S.
        • Eisenberg D.M.
        Trends in use of complementary and alternative medicine by US adults: 1997-2002.
        Altern Ther Health Med. 2005; 11: 42-49
        • Ernst E.
        Prevalence of use of complementary/alternative medicine: a systematic review.
        Bull World Health Organ. 2000; 78: 252-257
        • Xue C.C.
        • Zhang A.L.
        • Lin V.
        • Da Costa C.
        • Story D.F.
        Complementary and alternative medicine use in Australia: a national population-based survey.
        J Altern Complement Med. 2007; 13: 643-650
        • Fukuda S.
        • Watanabe E.
        • Ono N.
        • Tsubouchi M.
        • Shirakawa T.
        Use of complementary and alternative medicine and health problems.
        Nippon Koshu Eisei Zasshi. 2006; 53: 293-300
        • Nicholson T.
        Complementary and alternative medicines (including traditional Maori treatments) used by presenters to an emergency department in New Zealand: a survey of prevalence and toxicity.
        N Z Med J. 2006; 119: U1954
        • National Center for Complementary and Alternative Medicine
        (Accessed January 10, 2008)
        • Kam I.W.
        • Dennehy C.E.
        • Tsourounis C.
        Dietary supplement use among menopausal women attending a San Francisco health conference.
        Menopause. 2002; 9: 72-78
        • Hulley S.
        • Grady D.
        • Bush T.
        • et al.
        Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/Progestin Replacement Study (HERS) Research Group.
        JAMA. 1998; 280: 605-613
        • Rossouw J.E.
        • Anderson G.L.
        • Prentice R.L.
        • et al.
        • writing group for the Women's Health Initiative Investigators
        Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.
        JAMA. 2002; 288: 321-333
        • MacLennan A.H.
        • Taylor A.W.
        • Wilson D.H.
        Hormone therapy use after the Women's Health Initiative.
        Climacteric. 2004; 7: 138-142
        • Haas J.S.
        • Kaplan C.P.
        • Gerstenberger E.P.
        • Kerlikowske K.
        Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results.
        Ann Intern Med. 2004; 140: 184-188
        • Foster S.
        Black cohosh: Cimicifuga racemosa: a literature review.
        Herbal Gram. 1999; 45: 35-50
        • Nuntanakorn P.
        • Jiang B.
        • Einbond L.S.
        • et al.
        Polyphenolic constituents of Actaea racemosa.
        J Nat Prod. 2006; 69: 314-318
        • Fabricant D.S.
        • Nikolic D.
        • Lankin D.C.
        • et al.
        Cimipronidine, a cyclic guanidine alkaloid from Cimicifuga racemosa.
        J Nat Prod. 2005; 68: 1266-1270
        • Burdette J.E.
        • Liu J.
        • Chen S.N.
        • et al.
        Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor.
        J Agric Food Chem. 2003; 51: 5661-5670
        • American College of Obstetricians and Gynecologists
        Use of botanicals for management of menopausal symptoms: ACOG Practice Bulletin.
        Obstet Gynecol. 2001; 28: 1-11
        • Huntley A.
        • Ernst E.
        A systematic review of the safety of black cohosh.
        Menopause. 2003; 10: 58-64
        • Dog T.L.
        • Powell K.L.
        • Weisman S.M.
        Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief.
        Menopause. 2003; 10: 299-313
        • Kesselkaul O.
        Uber die Behandlung klimakterischer Beschwerden mit Remifemin.
        Med Monatsschr. 1957; 11: 87-88
        • Schotten E.W.
        Erfahrungen mit dem Cimicifuga-Praparat Remifemin.
        Landarzt. 1958; 34: 353-354
        • Stefan H.
        Ein Beitrag zu den erscheinungsformen und zur therapie hormonal bedingter biopathiesyndrome der Frau.
        Ringelheimer Biol Umsch. 1959; 14: 149-152
        • Foldes J.
        The actions of an extract of Cimicifuga racemosa.
        Arzneimittelforschung. 1959; 13: 623-624
        • Stiehler K.
        Uber die Anwendung eines standardisierten Cimicifuga-Auszuges in der Gynakologie.
        Arztliche Praxis. 1959; 11: 916-917
        • Heizer H.
        Kritisches zur Cimicifuga: therapie bei hormonalen storungen der Frau.
        Med Klin. 1960; 55: 232-233
        • Brucker A.
        Beitrag zur phytotherapie hormonaler storungen der frau.
        Med Welt. 1960; 44: 2331-2333
        • Starfinger W.
        Therapie mit oestrogen wirksamen Pfanzenextrakten.
        Med Heute. 1960; 9: 173-174
        • Gorlich N.
        Behandlung ovarieller storungen der frau in der allgemein-praxis.
        Arztliche Praxis. 1962; 14: 1742-1743
        • Langfritz W.
        Beitrag zur Therapie von Regelanomalien und deren Begleiterscheinungen bei jungen Madchen und jungen Frauen.
        Med Klin. 1962; 57: 1497-1499
        • Schildge E.
        Beitrag zur Behandlung von pramenstruellen und klimakterischen Vestimmungs und Depression-Zustanden.
        Ringelh Biol Umsch. 1964; 19: 18-22
        • Stolze H.
        An alternative to treat menopausal complaints.
        Gyne. 1982; 3: 14-16
        • Daiber W.
        Climacteric complaints: success without using hormones: a phytotherapeutic agent lessens hot flushes, sweating and insomnia.
        Arztliche Praxis. 1983; 35: 1946-1947
        • Vorberg G.
        Therapy of climateric complaints.
        Zeitschrift fur Allgemeinmedizin. 1984; 60: 626-629
        • Warnecke G.
        Influence of a phytopharmaceutical on climacteric complaints.
        Die Meizinisch Welt. 1985; 36: 871-874
        • Stoll W.
        Phytopharmacon influences atrophic vaginal epithelium: double-blind study: cimicifuga vs estrogenic substances.
        Therapeuticum. 1987; 1: 23-31
        • Petho A.
        Climacteric complaints are often helped with black cohosh.
        Arztliche Praxis. 1987; 47: 1551-1553
        • Lehmann W.E.
        • Riedel H.H.
        Clinical and endocrinologic examinations about therapy of climateric symptoms following hysterectomy with remaining ovaries.
        Zentralbl Gynakol. 1988; 110: 611-618
        • Duker E.M.
        • Kopanski L.
        • Jarry H.
        • Wuttke W.
        Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomised rats.
        Planta Med. 1991; 57: 420-424
        • Balier-Jagodzinski G.
        Praxisstudien mit Cimisan bei klimaterischen Beschwerden, Pramenstruellem Syndrom und Dysmenorrhoe.
        Natur Heilpraxis Naturmedizin. 1995; 48: 1284-1288
        • Georgiev D.B.
        • Iordanova E.
        Phytoestrogens: the alternative approach.
        Maturitas. 1997; 27: 213
        • Mielnik J.
        Extract of Cimicifuga racemosa in the treatment of neurovegetative symptoms in women in the perimenipausal period.
        Maturitas. 1997; 27: 215
        • Liske E.
        • Wustenberg P.
        Therapy of climacteric complaints with Cimicifuga racemosa: herbal medicine with clinically proven evidence.
        Menopause. 1998; 5: 250
        • Nesselhut T.
        • Liske E.
        Pharmacological measures in postmenopausal women with an isopropanolic aqueous extract of Cimicifuga racemosae rhizome.
        Menopause. 1999; 6: 1072-3714
        • Boblitz N.
        • Schrader E.
        • Henneicke-von Zepelin H.H.
        • Wustenberg P.
        Benefit of a a fixed drug combination containing St. John's wort and black cohosh for climateric patients: results of a randomized clinical trial.
        Focus alt Comp Ther (Fact). 2000; 5 (poster presentation from: 6th Annual Symposium on Complemetary Health Care; Exeter, England; December 2-4, 1999): 85-86
        • Jacobson J.S.
        • Troxel A.B.
        • Evans J.
        • et al.
        Randomised trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer.
        J Clin Oncol. 2001; 19: 2739-2745
        • Look R.M.
        • Morris K.T.
        • Homer L.
        • et al.
        Randomized controlled trial of venlafaxine versus black cohosh as a treatment for menopausal symptoms in women with breast cancer [abstract].
        Proc Am Soc Clin Oncol. 2001; 20 (abstract 2973): 305b
        • Cook A.
        • Pennington G.
        Phytoestrogen and multiple vitamin/mineral effects on bone mineral density in early postmenopausal women: a pilot study.
        J Womens Health Gend Based Med. 2002; 11: 53-60
        • Burke B.E.
        • Olson R.D.
        • Cusack B.J.
        Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine.
        Biomed Pharmacother. 2002; 56: 283-288
        • Liske E.
        • Hanggi W.
        • Henneicke-von Zepelin H.H.
        • Boblitz N.
        • Wustenberg P.
        • Rahlfs V.W.
        Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systematic estrogenic effect.
        J Womens Health Gend Based Med. 2002; 11: 163-174
        • Wuttke W.
        • Seidlová-Wuttke D.
        • Gorkow C.
        The Cimicifuga preparation BNO 1055 vs conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.
        Maturitas. 2003; 44: 67-77
        • Hernandez Munoz G.
        • Pluchino S.
        Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer.
        Maturitas. 2003; 44: 59-65
        • Morris K.
        • Look R.M.
        • Hudson V.
        • et al.
        The efficacy and safety of black cohosh for managing menopausal symptoms in breast cancer survivors [abstract].
        Breast Cancer Res Treat. 2003; 82: S159
        • Johnson B.M.
        • van Breemen R.B.
        In vitro formation of quinoid metabolites of the dietary supplement Cimicifuga racemosa (black cohosh).
        Chem Res Toxicol. 2003; 16: 838-846
        • Pockaj B.A.
        • Loprinzi C.L.
        • Sloan J.A.
        • et al.
        Pilot evaluation of black cohosh for the treatment of hot flashes in women.
        Cancer Invest. 2004; 22: 515-521
        • Osmers R.
        • Friede M.
        • Liske E.
        • Schnitker J.
        • Freudenstein J.
        • Henneicke-von Zepelin H.H.
        Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.
        Obstet Gynecol. 2005; 105: 1074-1083
        • Frei-Kleiner S.
        • Schaffner W.
        • Rahlfs V.W.
        • Bodmer C.
        • Birkhauser M.
        Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.
        Maturitas. 2005; 51: 397-404
        • Nappi R.E.
        • Malavasi B.
        • Brundu B.
        • Facchinetti F.
        Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol.
        Gynecol Endocrinol. 2005; 20: 30-35
        • Newton K.M.
        • Reed S.D.
        • Grothaus L.
        • et al.
        The Herbal Alternatives for Menopause (HALT) study: background and study design.
        Maturitas. 2005; 52: 134-146
        • Verhoeven M.O.
        • van der Mooren M.J.
        • van de Weijer P.H.
        • et al.
        • CuraTrial Research Group
        Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study.
        Menopause. 2005; 12: 412-420
        • Smolinski D.
        • Wollner D.
        • Orlowski J.
        • Curcio J.
        • Nevels J.
        • Kim L.S.
        A pilot study to examine a combination botanical for the treatment of menopausal symptoms.
        J Altern Complement Med. 2005; 11: 483-489
        • Schmidt M.
        • Polasek W.
        • Kaufeler R.
        Wirksamkeit und Sicherheit von Traubensilberkerze (Cimicifuga racemosa, Cimifemin®) bei Menopausebeschwerden: therapiebeobachtung unter Praxisbedingungen.
        J Menopause. 2005; 12: 27-32
        • Vermes G.
        • Banhidy F.
        • Acs N.
        The effects of remifemin on subjective symptoms of menopause.
        Adv Ther. 2005; 22: 148-154
        • Gurley B.J.
        • Gardner S.F.
        • Hubbard M.A.
        • et al.
        In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.
        Clin Pharmacol Ther. 2005; 77: 415-426
      1. Briese V, Stammwitz U, Friede M, Stefenelly U, Hnneicke-von Zepelin HH. Climateric therapy without hormones: results of a current observational cohort study. Presented at: Annual meeting of the German Menopause-Society on June 17-18, 2005, Munster, Germany.

        • Julia M.D.
        • Garcia Y.
        • Cano A.
        • Arriaza E.
        • Romeu A.
        A pilot study to assess changes in the quality of life in postmenopausal women after administration of Cimicifuga racemosa L., using the Cervantes scale.
        Climateric. 2005; 8 ([abstract]): 36
      2. Fischer J, Bartsch HH, Mumm A, Salier R, Stammwitz U, Rostock M. Prospective observational cohort study with a Cimicifuga racemosa extract (Remifemin) in breast cancer patients with climateric complaints undr therapy with tamoxifen. Presented at: Annual meeting of the German Menopause-Society on June 17-18, 2005, Munster, Germany.

      3. Henneicke-von Zepelin HH, Becher H, Schroder-Bernhardi D, Stammwith U. Pharmacoepidemiologic cohort study on the administration of Remifemin/Remifemin plus in patients with breast cancer, including hormone receptor-positive tumors. Presented at: Annual meeting of the German Menopause-Society on June 17-18, 2005, Munster, Germany.

      4. Von Schoultz B, Henneicke-von Zepelin HH, Liske E, Friede M, Hirschberg A. Clinical study on the drug safety of Remifemin with regard to breast epithelium cell proliferation and mammographic breast tissue density in postmenopausal women. Presented at: Annual meeting of the German Menopause-Society on June 17-18, 2005, Munster, Germany.

        • Henneicke-von Zepelin H.H.
        • Meden H.
        • Schroder-Bernhardi D.
        • Kostev K.
        • Becher H.
        Black cohosh and breast cancer recurrence-free survival.
        Maturitas. 2006; 54 ([abstract]): 58-59
        • Briese V.
        • Stammwitz U.
        • Henneicke-von Zepelin H.H.
        One year treatment with isopropanolic black cohosh extract (iCR).
        Maturitas. 2006; 54S ([abstract]): 18S
        • Uebelhack R.
        • Blohmer J.U.
        • Graubaum H.J.
        • Busch R.
        • Gruenwald J.
        • Wernecke K.D.
        Black cohosh and St. John's wort for climacteric complaints: a randomized trial.
        Obstet Gynecol. 2006; 107: 247-255
        • Bai W.
        • Henneicke-von Zepelin H.H.
        • Zheng S.
        • et al.
        Black cohosh versus tibolone in menopausal symptoms relief in Chinese women.
        Maturitas. 2006; 54 ([abstract]): 17
        • Raus K.
        • Brucker C.
        • Gorkow C.
        • Wuttke W.
        First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055.
        Menopause. 2006; 13: 678-691
        • Pockaj B.A.
        • Gallagher J.G.
        • Loprinzi C.L.
        • et al.
        Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
        J Clin Oncol. 2006; 24: 2836-2841
        • Wuttke W.
        • Gorkow C.
        • Seidlova-Wuttke D.
        Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study.
        Menopause. 2006; 13: 185-196
        • Guiltinan J.
        • Newton K.
        • Reed S.
        • LaCroix A.
        • Grothaus L.
        • Ehrlich K.
        Results of the Herbal Alternatives for Menopause (HALT) study.
        Alterna Ther. 2006; 12: 48-49
        • Gurley B.J.
        • Barone G.W.
        • Williams D.K.
        • et al.
        Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans.
        Drug Metab Dispos. 2006; 34: 69-74
        • Gurley B.
        • Hubbard M.A.
        • Williams D.K.
        • et al.
        Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin.
        J Clin Pharmacol. 2006; 46: 201-213
        • Newton K.M.
        • Reed S.D.
        • LaCroix A.Z.
        • Grothaus L.C.
        • Ehrlich K.
        • Guiltinan J.
        Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.
        Ann Intern Med. 2006; 145: 869-879
        • Radowicki S.
        • Skorzewska K.
        • Rudnicka E.
        • Szlendak-Sauer K.
        • Wierzba W.
        Effectiveness and safety of the treatment of menopausal syndrome with Cimicifuga racemosa dry extract.
        Ginekol Pol. 2006; 77: 678-683
        • Sammartino A.
        • Tommaselli G.A.
        • Gargano V.
        • Di Carlo C.
        • Attianese W.
        • Nappi C.
        Short-term effects of a combination of isoflavones, lignans and Cimicifuga racemosa on climacteric-related symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled trial.
        Gynecol Endocrinol. 2006; 22: 646-650
        • Hirschberg A.L.
        • Edlund M.
        • Svane G.
        • Azavedo E.
        • Skoog L.
        • Von Schoultz B.
        An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women.
        Menopause. 2007; 14: 89-96
        • Zepelin H.H.
        • Meden H.
        • Kostev K.
        • Schroder-Bernhardi D.
        • Stammwitz U.
        • Becher H.
        Isopropanolic black cohosh extract and recurrence-free survival after breast cancer.
        Int J Clin Pharmacol Ther. 2007; 45: 143-154
        • Verhoeven M.O.
        • Teerlink T.
        • Kenemans P.
        • Zuijdgeest-Van Leeuwen S.D.
        • Van Der Mooren M.J.
        Effects of a supplement containing isoflavones and actaea racemosa l. on asymmetric dimethylarginine, lipids, and c-reactive protein in menopausal women.
        Fertil Steril. 2007; 87: 849-857
        • Oktem M.
        • Eroglu D.
        • Karahan H.B.
        • Taskintuna N.
        • Kuscu E.
        • Zeyneloglu H.B.
        Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial.
        Adv Ther. 2007; 24: 448-461
        • Chung D.J.
        • Kim H.Y.
        • Park K.H.
        • et al.
        Black cohosh and St. John's wort (Gyno-Plus) for climacteric symptoms.
        Yonsei Med J. 2007; 48: 289-294
        • Rebbeck T.R.
        • Troxel A.B.
        • Norman S.
        • et al.
        A retrospective case-control study of the use of hormone-related supplements and association with breast cancer.
        Int J Cancer. 2007; 120: 1523-1528
        • Briese V.
        • Stammwitz U.
        • Friede M.
        • Henneicke-Von Zepelin H.H.
        Black cohosh with or without St. John's Wort for symptom-specific climacteric treatment-results of a large-scale, controlled, observational study.
        Maturitas. 2007; 57: 405-414
        • Van Der Sluijs C.P.
        • Bensoussan A.
        • Liyanage L.
        • Shah S.
        Women's health during mid-life survey: the use of complementary and alternative medicine by symptomatic women transitioning through menopause in Sydney.
        Menopause. 2007; 14: 397-403
        • Spangler L.
        • Newton K.M.
        • Grothaus L.C.
        • Reed S.D.
        • Ehrlich K.
        • Lacroix A.Z.
        The effects of black cohosh therapies on lipids, fibrinogen, glucose and insulin.
        Maturitas. 2007; 57: 195-204
        • Bai W.
        • Henneicke-Von Zepelin H.H.
        • Wang S.
        • et al.
        Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone.
        Maturitas. 2007; 58: 31-41
        • Anderson I.B.
        • Mullen W.H.
        • Meeker J.E.
        • et al.
        Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature.
        Ann Intern Med. 1996; 124: 726-734
        • Whiting P.W.
        • Clouston A.
        • Kerlin P.
        Black cohosh and other herbal remedies associated with acute hepatitis.
        Med J Aust. 2002; 177: 440-443
        • Frempong W.
        • Kiuru A.
        • Ericsson J.
        • Farah M.
        Cimicifuga racemosa L Nutt (black cohosh) and anaphylactic reactions, including face and oral oedema.
        (Accessed January 10, 2008)
        • Ingraffea A.
        • Donohue K.
        • Wilkel C.
        • Falanga V.
        Cutaneous vasculitis in two patients taking an herbal supplement containing black cohosh.
        J Am Acad Dermatol. 2007; 56: 124-126
        • Shuster J.
        ISMP adverse drug reactions.
        Hosp Pharm. 1996; 31: 1553-1554
        • Lontos S.
        • Jones R.M.
        • Angus P.W.
        • Gow P.J.
        Acute liver failure associated with the use of herbal preparations containing black cohosh.
        Med J Aust. 2003; 179: 390-391
        • Cohen S.M.
        • O'Connor A.M.
        • Hart J.
        • Merel N.H.
        • Te H.S.
        Autoimmune hepatitis associated with the use of black cohosh: a case study.
        Menopause. 2004; 11: 575-577
        • Levitsky J.
        • Alli T.A.
        • Wisecarver J.
        • Sorrell M.F.
        Fulminant liver failure associated with the use of black cohosh.
        Dig Dis Sci. 2005; 50: 538-539
        • Lynch C.R.
        • Folkers M.E.
        • Hutson W.R.
        Fulminant hepatic failure associated with the use of black cohosh: a case report.
        Liver Transpl. 2006; 12: 989-992
        • Minciullo P.L.
        • Saija A.
        • Patafi M.
        • Marotta G.
        • Ferlazzo B.
        • Gangemi S.
        Muscle damage induced by black cohosh (Cimicifuga racemosa).
        Phytomedicine. 2006; 13: 115-118
        • Meyer S.
        • Vogt T.
        • Obermann E.C.
        • Landthaler M.
        • Karrer S.
        Cutaneous pseudolymphoma induced by Cimicifuga racemosa.
        Dermatology. 2007; 214: 94-96
        • Dunbar K.
        • Solga S.F.
        Black cohosh, safety, and public awareness.
        Liver Int. 2007; 27: 1017-1018
      5. Order and Judgement 8: 05 CV 66, Grant and Beck vs Pharmavite LLC. United States District Court for the District of Nebraska. September 8, 2006.

      6. Amercian Herbal Products Association. Press release: US District Court dismisses experts and lawsuit in black cohosh complaint. September 18, 2006.

        • Blumenthal M.
        • Ferrier G.K.L.
        • Cavaliere C.
        Total sales of herbal supplements in United States show steady growth.
        HerbalGram. 2006; 71: 64-66
        • Engel W.
        In vivo studies on the metabolism of the monoterpene pulegone in humans using the metabolism of ingestion-correlated amounts (MICA) approach: explanation for the toxicity differences between (S)-(–)- and (R)-(+)-pulegone.
        J Agric Food Chem. 2003; 51: 6589-6597
        • Nelson S.D.
        Mechanisms of the formation and disposition of reactive metabolites that can cause acute liver injury.
        Drug Metab Rev. 1995; 27: 147-177
        • Chatterjee P.
        • Franklin M.R.
        Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components.
        Drug Metab Dispos. 2003; 31: 1391-1397
        • Gordon E.
        • Devinsky O.
        Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy.
        Epilepsia. 2001; 42: 1266-1272
        • Miller L.G.
        Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions.
        Arch Intern Med. 1998; 158: 2200-2211
        • Thomsen M.
        • Vitetta L.
        • Sali A.
        • Schmidt M.
        Acute liver failure associated with the use of herbal preparations containing black cohosh.
        Med J Aust. 2004; 180: 598-599
        • Thomsen M.
        • Schmidt M.
        Hepatotoxizität durch Cimicifuga racemosa?.
        Z Phytother. 2003; 24: 11-14
        • Bone K.
        Phytotherapy review and commentary.
        Townsend Letter for Doctors and Patients. 2006; (July): 66-70
        • Freudenstein J.
        • Dasenbrock C.
        • Nisslein T.
        Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract.
        Cancer Res. 2002; 62: 3448-3452
        • Bodinet C.
        • Freudenstein J.
        Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells.
        Breast Cancer Res Treat. 2002; 76: 1-10
        • Hostanska K.
        • Nisslein T.
        • Freudenstein J.
        • Reichling J.
        • Saller R.
        Evaluation of cell death caused by triterpene glycosides and phenolic substances from Cimicifuga racemosa extract in human MCF-7 breast cancer cells.
        Biol Pharm Bull. 2004; 27: 1970-1975
        • Stromeier S.
        • Petereit F.
        • Nahrstedt A.
        Phenolic esters from the rhizomes of Cimicifuga racemosa do not cause proliferation effects in MCF-7 cells.
        Planta Med. 2005; 71: 495-500
        • Stute P.
        • Nisslein T.
        • Gotte M.
        • Kamischke A.
        • Kiesel L.
        • Klockenbusch W.
        Effects of black cohosh on estrogen biosynthesis in normal breast tissue in vitro.
        Maturitas. 2007; 57: 382-391
        • Nisslein T.
        • Freudenstein J.
        Concomitant administration of an isopropanolic extract of black cohosh and tamoxifen in the in vivo tumor model of implanted RUCA-I rat endometrial adenocarcinoma cells.
        Toxicol Lett. 2004; 150: 271-275
        • Hostanska K.
        • Nisslein T.
        • Freudenstein J.
        • Reichling J.
        • Saller R.
        Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis.
        Breast Cancer Res Treat. 2004; 84: 151-160
        • Einbond L.S.
        • Shimizu M.
        • Nuntanakorn P.
        • et al.
        Actein and a fraction of black cohosh potentiate antiproliferative effects of chemotherapy agents on human breast cancer cells.
        Planta Med. 2006; 72: 1200-1206
        • Einbond L.S.
        • Su T.
        • Wu H.A.
        • et al.
        The growth inhibitory effect of actein on human breast cancer cells is associated with activation of stress response pathways.
        Int J Cancer. 2007; (Epub ahead of print)
        • Einbond L.S.
        • Su T.
        • Wu H.A.
        • et al.
        Gene expression analysis of the mechanisms whereby black cohosh inhibits human breast cancer cell growth.
        Anticancer Res. 2007; 27: 697-712
        • Rockwell S.
        • Liu Y.
        • Higgins S.A.
        Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh.
        Breast Cancer Res Treat. 2005; 90: 233-239
        • Tsukamoto S.
        • Aburatani M.
        • Ohta T.
        Isolation of CYP3A4 inhibitors from the black cohosh (Cimicifuga racemosa).
        Evid Based Complement Alternat Med. 2005; 2: 223-226